pharmaceutical investing Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial
pharmaceutical investing Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
SAGA Metals Positions Wolverine Heavy REE Project Alongside Strange Lake and Tanbreez in Geological Peer Comparison
Standard Uranium Confirms Strong Radioactivity up to 48,000 cps at Surface and Discovers New Showings at the Corvo Uranium Project
